Endoscopic ultrasound-guided fine-needle aspiration in patients with non-small cell lung cancer and prior negative mediastinoscopy
- PMID: 16181845
- DOI: 10.1016/j.athoracsur.2005.04.001
Endoscopic ultrasound-guided fine-needle aspiration in patients with non-small cell lung cancer and prior negative mediastinoscopy
Abstract
Background: Mediastinoscopy and endoscopic ultrasound-guided fine-needle aspiration biopsy (EUS-FNA) are complementary for staging non-small cell lung cancer (NSCLC) patients. We assessed (1) the yield of EUS-FNA of malignant lymph nodes in NSCLC patients with combined anterior and posterior lymph nodes that had already undergone mediastinoscopy and (2) the cost implications associated with alternative initial strategies.
Methods: All patients underwent chest computed tomography (CT) and/or positron emission tomography (PET), and mediastinoscopy. Then, the posterior mediastinal stations (7, 8, and 9) or station 5 were targeted with EUS-FNA. The reference standard included thoracotomy with complete thoracic lymphadenectomy, repeat clinical imaging, or long-term clinical follow-up. A Monte Carlo cost-analysis model evaluated the expected costs and outcomes associated with staging of NSCLC.
Results: Thirty-five NSCLC patients met inclusion criteria (median age 65 years; 80% men). Endoscopic ultrasound-guided FNA was performed in 53 lymph nodes in various stations, the subcarinal station (7) being the most common (47.3%). Of the 35 patients who had a prior negative mediastinoscopy, 13 patients (37.1%) had malignant N2 or N3 lymph nodes. Accuracy of EUS-FNA (98.1%) was significantly higher than that of CT (41.5%; p < 0.001) and PET (40%; p < 0.001). Initial EUS-FNA resulted in average costs per patient of 1,867 dollars (SD +/- 4,308 dollars) while initial mediastinoscopy cost 12,900 dollars (SD +/- 4,164.40 dollars). If initial EUS-FNA is utilized rather than initial mediastinoscopy, an average cost saving of 11,033 dollars per patient would result.
Conclusions: In patients with NSCLC and combined anterior and posterior lymph nodes, starting with EUS-FNA would preclude mediastinoscopy in more than one third of the patients. Endoscopic ultrasound-guided FNA is a safe outpatient procedure that is less invasive and less costly than mediastinoscopy.
Comment in
-
Invited commentary.Ann Thorac Surg. 2005 Oct;80(4):1239-40. doi: 10.1016/j.athoracsur.2005.07.008. Ann Thorac Surg. 2005. PMID: 16181846 No abstract available.
Similar articles
-
Endoscopic ultrasound-guided fine needle aspiration of mediastinal lymph node in patients with suspected lung cancer after positron emission tomography and computed tomography scans.Ann Thorac Surg. 2005 Jan;79(1):263-8. doi: 10.1016/j.athoracsur.2004.06.089. Ann Thorac Surg. 2005. PMID: 15620955 Clinical Trial.
-
Routine mediastinoscopy and esophageal ultrasound fine-needle aspiration in patients with non-small cell lung cancer who are clinically N2 negative: a prospective study.Chest. 2006 Dec;130(6):1791-5. doi: 10.1378/chest.130.6.1791. Chest. 2006. PMID: 17166998
-
The complete ''medical'' mediastinoscopy (EUS-FNA + EBUS-TBNA).Minerva Med. 2007 Aug;98(4):331-8. Minerva Med. 2007. PMID: 17921946 Review.
-
Endoscopic ultrasound added to mediastinoscopy for preoperative staging of patients with lung cancer.JAMA. 2005 Aug 24;294(8):931-6. doi: 10.1001/jama.294.8.931. JAMA. 2005. PMID: 16118383
-
Current concepts in the mediastinal lymph node staging of nonsmall cell lung cancer.Ann Surg. 2003 Aug;238(2):180-8. doi: 10.1097/01.SLA.0000081086.37779.1a. Ann Surg. 2003. PMID: 12894010 Free PMC article. Review.
Cited by
-
Mediastinal staging of NSCLC with endoscopic and endobronchial ultrasound.Nat Rev Clin Oncol. 2009 May;6(5):278-86. doi: 10.1038/nrclinonc.2009.39. Nat Rev Clin Oncol. 2009. PMID: 19390554 Free PMC article. Review.
-
Esophageal assessments of left ventricular filling pressures: A proof-of-concept study.Int J Crit Illn Inj Sci. 2014 Jan;4(1):18-23. doi: 10.4103/2229-5151.128008. Int J Crit Illn Inj Sci. 2014. PMID: 24741493 Free PMC article.
-
Performance of EUS-FNA for mediastinal lymphadenopathy: impact on patient management and costs in low-volume EUS centers.Surg Endosc. 2010 Sep;24(9):2260-7. doi: 10.1007/s00464-010-0946-9. Epub 2010 Feb 23. Surg Endosc. 2010. PMID: 20177920 Free PMC article.
-
[Role of mediastinoscopy and repeat mediastinoscopy today].Chirurg. 2008 Jan;79(1):38, 40-4. doi: 10.1007/s00104-007-1447-9. Chirurg. 2008. PMID: 18209980 Review. German.
-
Combined use of EUS-guided FNA and immunocytochemical stains discloses metastatic and unusual diseases in the evaluation of mediastinal lymphadenopathy of unknown etiology.Ann Thorac Med. 2012 Apr;7(2):84-91. doi: 10.4103/1817-1737.94527. Ann Thorac Med. 2012. PMID: 22558013 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous